ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5.
Yang Y, Gao Y, Huang J, Yang Z, Luo H, Wang F, Xu J, Cui Y, Ding H, Lin Z, Zhai X, Qu Y, Zhang L, Liu T, Ye L, Niu T, Zheng Y.
Yang Y, et al. Among authors: wang f.
JCI Insight. 2022 Oct 10;7(19):e157081. doi: 10.1172/jci.insight.157081.
JCI Insight. 2022.
PMID: 36040812
Free PMC article.